Bank Julius Baer & Co
COGT icon

Bank Julius Baer & Co’s Cogent Biosciences COGT Stock Holding History

Bank Julius Baer & Co’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-123
Closed -$1K – 814
2021
Q2 		$1K Buy
123
+57
+86% +$481 ﹤0.01% 818
2021
Q1 		$1K Sell
66
-23
-26% -$221 ﹤0.01% 812
2020
Q4 		$1K Sell
89
-486
-85% -$5.34K ﹤0.01% 799
2020
Q3 		$5K Hold
575
– – ﹤0.01% 703
2020
Q2 		$1K Sell
575
-30
-5% -$56 ﹤0.01% 662
2020
Q1 		$1K Buy
+605
New +$1.68K ﹤0.01% 628

Other funds holding COGT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Bank Julius Baer & Co's COGT Position: Q3 2021 in Review

Bank Julius Baer & Co sold out of Cogent Biosciences (COGT) in Q3 2021, closing a stake of 123 shares — an estimated $1K sold.

Bank Julius Baer & Co first reported a position in COGT in Q1 2020 and held it in 6 quarters. The position peaked at $5K in Q3 2020. 73 funds tracked by Wall St. Rank hold COGT as of Q3 2021.

  • Bank Julius Baer & Co reported no remaining Cogent Biosciences position as of Q3 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 123 Cogent Biosciences shares in Q3 2021, an estimated $1K.
  • Bank Julius Baer & Co first reported a position in Cogent Biosciences in Q1 2020 and held it in 6 quarters.
  • Bank Julius Baer & Co's Cogent Biosciences position peaked at $5K in Q3 2020.
  • 73 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2021.

Based on Bank Julius Baer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.